| Product Code: ETC9514298 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import shipments of intravenous antibodies show a shift in concentration towards key exporting countries like Peru, Netherlands, USA, Brazil, and Germany in 2024. The Herfindahl-Hirschman Index (HHI) indicates a significant increase in market concentration, reflecting the dominance of these countries in supplying intravenous antibodies to Suriname. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) of 2.08% over the period 2020-24 suggests steady expansion in the market. This trend highlights the importance of these top exporting countries in meeting Suriname demand for intravenous antibodies.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Intravenous Antibodies Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Intravenous Antibodies Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Intravenous Antibodies Market - Industry Life Cycle |
3.4 Suriname Intravenous Antibodies Market - Porter's Five Forces |
3.5 Suriname Intravenous Antibodies Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Intravenous Antibodies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Intravenous Antibodies Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Suriname Intravenous Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Intravenous Antibodies Market Trends |
6 Suriname Intravenous Antibodies Market, By Types |
6.1 Suriname Intravenous Antibodies Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Intravenous Antibodies Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Intravenous Antibodies Market Revenues & Volume, By IgG, 2021- 2031F |
6.1.4 Suriname Intravenous Antibodies Market Revenues & Volume, By IgA, 2021- 2031F |
6.1.5 Suriname Intravenous Antibodies Market Revenues & Volume, By IgM, 2021- 2031F |
6.1.6 Suriname Intravenous Antibodies Market Revenues & Volume, By IgE, 2021- 2031F |
6.1.7 Suriname Intravenous Antibodies Market Revenues & Volume, By IgD, 2021- 2031F |
6.2 Suriname Intravenous Antibodies Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Intravenous Antibodies Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Suriname Intravenous Antibodies Market Revenues & Volume, By Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), 2021- 2031F |
6.2.4 Suriname Intravenous Antibodies Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura, 2021- 2031F |
6.2.5 Suriname Intravenous Antibodies Market Revenues & Volume, By Hypogammaglobulinemia, 2021- 2031F |
6.2.6 Suriname Intravenous Antibodies Market Revenues & Volume, By Myasthenia Gravis, 2021- 2031F |
6.2.7 Suriname Intravenous Antibodies Market Revenues & Volume, By Multifocal Motor Neuropathy, 2021- 2031F |
6.2.8 Suriname Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Suriname Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Intravenous Antibodies Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Intravenous Antibodies Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Suriname Intravenous Antibodies Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Suriname Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Intravenous Antibodies Market Import-Export Trade Statistics |
7.1 Suriname Intravenous Antibodies Market Export to Major Countries |
7.2 Suriname Intravenous Antibodies Market Imports from Major Countries |
8 Suriname Intravenous Antibodies Market Key Performance Indicators |
9 Suriname Intravenous Antibodies Market - Opportunity Assessment |
9.1 Suriname Intravenous Antibodies Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Intravenous Antibodies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Intravenous Antibodies Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Suriname Intravenous Antibodies Market - Competitive Landscape |
10.1 Suriname Intravenous Antibodies Market Revenue Share, By Companies, 2024 |
10.2 Suriname Intravenous Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |